In the structured educational cost-effectiveness study conducted by Pollard et al. (30), participants with T1DM treated with insulin pumps experienced high intervention costs, largely due to the expense of insulin pump therapy. The gene discussed is INS; the disease is type 1 diabetes mellitus.